Publicaciones en colaboración con investigadores/as de Hospital Virgen de La Luz de Cuenca (39)

2023

  1. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

    Thrombosis Update, Vol. 13

  2. Machine learning to predict major bleeding during anticoagulation for venous thromboembolism: possibilities and limitations

    British Journal of Haematology, Vol. 201, Núm. 5, pp. 971-981

2021

  1. Multiple vertebral fractures after suspension of denosumab. A series of 56 cases

    International Journal of Clinical Practice, Vol. 75, Núm. 10

2020

  1. First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry

    Thrombosis Update, Vol. 1

2019

  1. Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years

    Scientific Reports, Vol. 9, Núm. 1

  2. Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry

    Orphanet Journal of Rare Diseases, Vol. 14, Núm. 1

2018

  1. Human immunodeficiency virus/hepatits C virus coinfection in Spain: Elimination is feasible, but the burden of residual cirrhosis will be significant

    Open Forum Infectious Diseases, Vol. 5, Núm. 1

  2. Influence of baseline MELD score in the efficacy of treatment of hepatitis C with simeprevir and sofosbuvir

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 36, Núm. 5, pp. 277-283

  3. Prognosis of venous thromboembolism in orthopaedic surgery or trauma patients and use of thromboprophylaxis

    Revista Clinica Espanola, Vol. 218, Núm. 8, pp. 399-407

  4. Real world patient-reported outcomes in HIV-infected adults switching to EVIPLERA®, because of a previous intolerance to cART. PRO-STR study

    Current HIV Research, Vol. 16, Núm. 6, pp. 425-435

  5. Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism

    American Journal of Medicine, Vol. 131, Núm. 4, pp. 430-437

2017

  1. Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism

    Research and Practice in Thrombosis and Haemostasis, Vol. 1, Núm. 2, pp. 172-179

2016

  1. Human immunodeficiency virus/hepatitis C virus coinfection in Spain: Prevalence and patient characteristics

    Open Forum Infectious Diseases, Vol. 3, Núm. 2

2015

  1. Fatal events in cancer patients receiving anticoagulant therapy for venous thromboembolism

    Medicine (United States), Vol. 94, Núm. 32

  2. Rivaroxaban in the treatment of venous thromboembolism and the prevention of recurrences: A practical approach

    Clinical and Applied Thrombosis/Hemostasis, Vol. 21, Núm. 4, pp. 297-308

2013

  1. Relationship between volume and survival in closed intensive care units is weak and apparent only in mechanically ventilated patients

    Anesthesiology, Vol. 119, Núm. 4, pp. 871-879

2012

  1. Measurement of asthma control according to global initiative for asthma guidelines: a comparison with the asthma control questionnaire

    Respiratory Research, Vol. 13

  2. The undiagnosed cases of Clostridium difficile infection in a whole nation: Where is the problem?

    Clinical Microbiology and Infection, Vol. 18, Núm. 7

2011

  1. Lipid profiles and oxidative stress parameters in male and female hemodialysis patients

    Molecular and Cellular Biochemistry, Vol. 353, Núm. 1-2, pp. 59-63

2009

  1. A Woman With Increasing Dypsnea

    Gastroenterology